Cake and Gold: A Sweet Business Combination Introduction: Vancouver, British Columbia–(Newsfile Corp. – December 31, 2024) – Radio Fuels Energy Corp. (CSE: CAKE) (OTCQB: CKEFF) (the “Company” or “Radio Fuels”) is pleased to announce that it has filed and commenced delivery of the notice of meeting and management information circular of the Company (the “Circular”)…

AstraZeneca Stock Plummets as China Investigation Unfolds In a Nutshell It’s been a rough ride for AstraZeneca, the pharmaceutical powerhouse that has seen its stock take a significant hit in the wake of troubling developments in China. The Drama Unfolds Over the past six months, AstraZeneca’s stock price has plummeted by 15 percent, thanks in…

Investor Alert: Pomerantz LLP Announces Class Action Lawsuit Against Kyverna Therapeutics, Inc. New York, NY / ACCESSWIRE / December 29, 2024 / Pomerantz LLP, a leading law firm specializing in securities litigation, has announced that a class action lawsuit has been filed against Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQ:KYTX). Investors who have suffered…

Investing in Myers Industries: A Patient Investor’s Dream The Road to Recovery Myers Industries’ recent struggles have been well-documented, with lowered EPS guidance causing concern among investors. However, the company’s recent acquisition of Signature Systems presents a glimmer of hope, with expected synergies and profitability improvements on the horizon. A Plan for Success Myers Industries’…

Supporting the Family of Fallen Trooper Clay Carns Illinois State Police Rally Around Loved Ones Remembering Trooper Clay Carns Illinois State Police are rallying around the family of one of their own, with the creation of a fundraiser in support of the family of fallen Trooper Clay Carns. Carns, 35, tragically lost his life just…

TScan Therapeutics, Inc. Secures $30 Million Financing Deal Breaking News: TScan Therapeutics Enters into Securities Purchase Agreement WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company, has announced a significant milestone in its quest to develop innovative cancer therapies. The company has entered into a securities purchase…